Bob Roskamp hoped his drug discovery institute would be thriving without his help by now. The developer and philanthropist imagined 200 scientists and a steady cash flow from the discovery that a hypertension drug could also treat Alzheimer’s disease.
Instead, more than a dozen years after founding The Roskamp Institute, Roskamp is still writing personal checks to help support its $5 million-plus budget and the 50 scientists who work in its local labs. And his team is still working to secure funding from pharmaceutical companies and venture capitalists to test the drug they believe will cure Alzheimer’s.
Click headline to read the entire Sarasota Herald-Tribune article